Searle E, Lesokhin A, Niesvizky R, Arnulf B, Larson S, Strouse C, Fernandez De Larrea C, Vesole D, Nagai Y, Sullivan S, Leip E, Bahlis N. P35 | PROLONGED ELRANATAMAB TREATMENT INTERRUPTION IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MagnetisMM-3 RETROSPECTIVE ANALYSIS. haematol [Internet]. 2026Apr.15 [cited 2026Apr.21];111(s2). Available from: https://haematologica.org/article/view/haematol.2026.s2.14090